Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.970
+0.040 (2.07%)
At close: Dec 20, 2024, 4:00 PM
1.960
-0.010 (-0.51%)
After-hours: Dec 20, 2024, 7:43 PM EST

PACB Revenue

Pacific Biosciences of California had revenue of $39.97M in the quarter ending September 30, 2024, a decrease of -28.23%. This brings the company's revenue in the last twelve months to $173.15M, up 2.14% year-over-year. In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth.

Revenue (ttm)
$173.15M
Revenue Growth
+2.14%
P/S Ratio
3.08
Revenue / Employee
$217,521
Employees
796
Market Cap
539.51M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.